Circular RNA hsa_circ_0002360 promotes non-small cell lung cancer progression through upregulating matrix metalloproteinase 16 and sponging multiple micorRNAs

References

• Jonna S, Subramaniam DS. Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update. Discov Med. 2019;27(148):167–170.
   PubMed Web of Science ®Google Scholar
• Lee SS, Cheah YK. The interplay between microRNAs and cellular components of Tumour Microenvironment (TME) on Non-Small-Cell Lung Cancer (NSCLC) progression. J Immunol Res. 2019;2019:3046379.
   PubMed Web of Science ®Google Scholar
• Chen Z, Fillmore CM, Hammerman PS, et al. Wong KK: non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014;14(8):535–546.
   PubMed Web of Science ®Google Scholar
• How CW, Ong YS, Low SS, et al. How far have we explored fungi to fight cancer? Semin Cancer Biol.
   Google Scholar
• Li X, Yang L, Chen -L-L. The biogenesis, functions, and challenges of circular RNAs. Mol Cell. 2018;71(3):428–442.
   PubMed Web of Science ®Google Scholar
• Salzman J. Circular RNA expression: its potential regulation and function. Trends Genet. 2016;32(5):309–316.
   PubMed Web of Science ®Google Scholar
• Hu X, Wang P, Qu C, et al. Li L: circular RNA Circ_0000677 promotes cell proliferation by regulating microRNA-106b-5p/CCND1 in non-small cell lung cancer. Bioengineered. 2021;12(1):6229–6239.
   PubMed Web of Science ®Google Scholar
• Fang G, Chen T, Mao R, et al. Circular RNA circ_0089153 acts as a competing endogenous RNA to regulate colorectal cancer development by the miR-198/SUMO-specific peptidase 1 (SENP1) axis. Bioengineered. 2021;12(1):5664–5678.
   PubMed Web of Science ®Google Scholar
• Li X, Yang B, Ren H, et al. Zhang W: hsa_circ_0002483 inhibited the progression and enhanced the taxol sensitivity of non-small cell lung cancer by targeting miR-182-5p. Cell Death Dis. 2019;10(12):953.
   PubMedGoogle Scholar
• Lu Q, Liu T, Feng H, et al. Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN. Mol Cancer. 2019;18(1):111.
   PubMed Web of Science ®Google Scholar
• Yang G, Zhang T, Ye J, et al. Ma J: circ-ITGA7 sponges miR-3187-3p to upregulate ASXL1, suppressing colorectal cancer proliferation. Cancer Manag Res. 2019;11:6499–6509.
   PubMed Web of Science ®Google Scholar
• Yan Y, Zhang R, Zhang X, et al. RNA-Seq profiling of circular RNAs and potential function of hsa_circ_0002360 in human lung adenocarcinom. Am J Transl Res. 2019;11(1):160–175.
   PubMed Web of Science ®Google Scholar
• Dudekula DB, Panda AC, Grammatikakis I, et al. Gorospe M: circInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2016;13(1):34–42.
   PubMed Web of Science ®Google Scholar
• McGeary SE, Lin KS, Shi CY, et al. The biochemical basis of microRNA targeting efficacy. Science. 2019;366(6472):eaav1741.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Mesirov JP: gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550.
   PubMed Web of Science ®Google Scholar
• Weinstein JN, Collisson EA, Mills GB, et al., Cancer Genome Atlas Research Network. The cancer genome atlas pan-cancer analysis project. Nat Genet. 2013;45(10):1113–1120.
   PubMed Web of Science ®Google Scholar
• Zhang G, Li S, Lu J, et al. LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer. (Electronic). 1476–4598.
   Google Scholar
• Patop IL, Kadener S. Kadener S: circRNAs in Cancer. Curr Opin Genet Dev. 2018;48:121–127.
   PubMed Web of Science ®Google Scholar
• Patop IL, Wüst S, Kadener S. Past, present, and future of circRNAs. EMBO J. 2019;38(16):e100836.
   PubMed Web of Science ®Google Scholar
• Hsiao KY, Sun HS, Tsai SJ. Circular RNA - New member of noncoding RNA with novel functions. Exp Biol Med (Maywood). 2017;242(11):1136–1141.
   PubMed Web of Science ®Google Scholar
• Du WW, Zhang C, Yang W, et al. Identifying and characterizing circRNA-Protein Interaction. Theranostics. 2017;7(17):4183–4191.
   PubMed Web of Science ®Google Scholar
• Wang Z, Lei X, Wu FX. Identifying cancer-specific circRNA-RBP binding sites based on deep learning. Molecules (Basel, Switzerland). 2019; 24(22)
   Web of Science ®Google Scholar
• Ma X, Liu C, Gao C, et al. circRNA-associated ceRNA network construction reveals the circRNAs involved in the progression and prognosis of breast cancer. J Cell Physiol. 2020;235(4):3973–3983.
   PubMed Web of Science ®Google Scholar
• Zhang CC, Li Y, Feng XZ, et al. Circular RNA circ_0001287 inhibits the proliferation, metastasis, and radiosensitivity of non-small cell lung cancer cells by sponging microRNA miR-21 and up-regulating phosphatase and tensin homolog expression. Bioengineered. 2021;12(1):414–425.
   PubMed Web of Science ®Google Scholar
• Syed SN, Brune B. MicroRNAs as emerging regulators of signaling in the tumor microenvironment. Cancers (Basel). 2020;12(4):4.
   Web of Science ®Google Scholar
• Cai K, Li HX, Li PP, et al. MicroRNA-449b-3p inhibits epithelial-mesenchymal transition by targeting IL-6 and through the JAK2/STAT3 signaling pathway in non-small cell lung cancer. Exp Ther Med. 2020;19(4):2527–2534.
   PubMed Web of Science ®Google Scholar
• Cai J, Fang L, Huang Y, et al. Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC. Nat Commun. 2017;8(1):15870.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Wu Q, Zhang M, et al. Hsa_circ_0016760 exacerbates the malignant development of non‑small cell lung cancer by sponging miR‑145‑5p/FGF5. Oncol Rep. 2020;45(2):501–512.
   PubMed Web of Science ®Google Scholar
• Ma Y, Pan X, Xu P, et al. An HX: plasma microRNA alterations between EGFR-activating mutational NSCLC patients with and without primary resistance to TKI. Oncotarget. 2017;8(51):88529–88536.
   PubMedGoogle Scholar
• Li XM, Yu Z, Huai M, et al. [miR-758-3p inhibits the proliferation and invasion of non-small cell lung cancer cells by targeting NUSAP1]. Zhonghua Zhong Liu Za Zhi. 2021;43(1):113–117.
   PubMedGoogle Scholar
• Uppal A, Wightman SC, Mallon S, et al. 14q32-encoded microRNAs mediate an oligometastatic phenotype. Oncotarget. 2015;6(6):3540–3552.
   PubMedGoogle Scholar
• Wu S, Ma C, Shan S, et al. High expression of matrix metalloproteinases 16 is associated with the aggressive malignant behavior and poor survival outcome in colorectal carcinoma. Sci Rep. 2017;7(1):46531.
   PubMedGoogle Scholar
• Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69(3):562–573.
   PubMed Web of Science ®Google Scholar
• Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141(1):52–67.
   PubMed Web of Science ®Google Scholar
• Sun DW, Zhang YY, Qi Y, et al. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis. Cancer Epidemiol. 2015;39(2):135–142.
   PubMed Web of Science ®Google Scholar
• Tatti O, Gucciardo E, Pekkonen P, et al. MMP16 mediates a proteolytic switch to promote cell-cell adhesion, collagen alignment, and lymphatic invasion in melanoma. Cancer Res. 2015;75(10):2083–2094.
   PubMed Web of Science ®Google Scholar
• Cao L, Chen C, Zhu H, et al. MMP16 is a marker of poor prognosis in gastric cancer promoting proliferation and invasion. Oncotarget. 2016;7(32):51865–51874.
   PubMedGoogle Scholar
• Wang H, Li XT, Wu C, et al. miR-132 can inhibit glioma cells invasion and migration by target MMP16 in vitro. Onco Targets Ther. 2015;8:3211–3218.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang H, Dong Y, et al. MiR-146b-5p functions as a suppressor miRNA and prognosis predictor in non-small cell lung cancer. J Cancer. 2017;8(9):1704–1716.
   PubMed Web of Science ®Google Scholar